BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21108793)

  • 21. Optimization and evaluation of the ARCHITECT Chagas assay and in-house ELISA for Chagas disease in clinical settings in Japan.
    Imai K; Murakami T; Misawa K; Fujikura Y; Kawana A; Tarumoto N; Maesaki S; Maeda T
    Parasitol Int; 2021 Feb; 80():102221. PubMed ID: 33137505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of chemiluminescence and PCR effectiveness in relation to conventional serological tests for the diagnosis of Chagas' disease.
    Duarte AM; de Andrade HM; do Monte SJ; de Toledo Vde P; Guimarães TM
    Rev Soc Bras Med Trop; 2006; 39(4):385-7. PubMed ID: 17119757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].
    Llano M; Pavía P; Flórez AC; Cuéllar A; González JM; Puerta C
    Biomedica; 2014; 34(2):228-36. PubMed ID: 24967928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of serological tests for diagnosis of chronic pulmonary aspergillosis: A systematic review and meta-analysis.
    Volpe Chaves CE; do Valle Leone de Oliveira SM; Venturini J; Grande AJ; Sylvestre TF; Poncio Mendes R; Mello Miranda Paniago A
    PLoS One; 2020; 15(3):e0222738. PubMed ID: 32182249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
    Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
    Cochrane Database Syst Rev; 2015 Oct; (10):CD009551. PubMed ID: 26424726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.
    Cruciani M; Mengoli C; Loeffler J; Donnelly P; Barnes R; Jones BL; Klingspor L; Morton O; Maertens J
    Cochrane Database Syst Rev; 2015 Sep; (9):CD009551. PubMed ID: 26343815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular diagnosis of experimental Chagas disease.
    Andersson J
    Trends Parasitol; 2004 Feb; 20(2):52-3. PubMed ID: 14747014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.
    Schijman AG; Bisio M; Orellana L; Sued M; Duffy T; Mejia Jaramillo AM; Cura C; Auter F; Veron V; Qvarnstrom Y; Deborggraeve S; Hijar G; Zulantay I; Lucero RH; Velazquez E; Tellez T; Sanchez Leon Z; Galvão L; Nolder D; Monje Rumi M; Levi JE; Ramirez JD; Zorrilla P; Flores M; Jercic MI; Crisante G; Añez N; De Castro AM; Gonzalez CI; Acosta Viana K; Yachelini P; Torrico F; Robello C; Diosque P; Triana Chavez O; Aznar C; Russomando G; Büscher P; Assal A; Guhl F; Sosa Estani S; DaSilva A; Britto C; Luquetti A; Ladzins J
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e931. PubMed ID: 21264349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of different Trypanosoma cruzi antigens in the diagnosis of Chagas disease in patients with American cutaneous leishmaniasis from a co-endemic region in Argentina.
    Vega Benedetti AF; Cimino RO; Cajal PS; Juarez MDV; Villalpando CA; Gil JF; Marcipar IS; Krolewiecki AJ; Nasser JR
    Trop Med Int Health; 2013 Sep; 18(9):1103-1109. PubMed ID: 23837449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of high quality diagnostic tests for Chagas disease.
    Afonso AM; Ebell MH; Tarleton RL
    PLoS Negl Trop Dis; 2012; 6(11):e1881. PubMed ID: 23145201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of commercial kits used for Chagas disease diagnosis in blood banks in Chile. II. Routine application].
    Lorca M; Child R; García A; Silva M; Martínez L; Jerez G; Toledo I; Mezzano D
    Rev Med Chil; 1994 Aug; 122(8):925-31. PubMed ID: 7761723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diffusion-in-gel enzyme-linked immunosorbent assay (DIG-ELISA) for Chagas' disease serodiagnosis.
    Requejo HI; Nakamura PM; Vaz AJ; Pialarissi CS; Hoshino-Shimizu S; Matsumoto TK; Nakamura H
    Braz J Med Biol Res; 1991; 24(5):471-83. PubMed ID: 1823262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological evaluation for Chagas disease in migrants from Latin American countries resident in Rome, Italy.
    Pane S; Giancola ML; Piselli P; Corpolongo A; Repetto E; Bellagamba R; Cimaglia C; Carrara S; Ghirga P; Oliva A; Bevilacqua N; Al Rousan A; Nisii C; Ippolito G; Nicastri E
    BMC Infect Dis; 2018 May; 18(1):212. PubMed ID: 29739357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic Chagas' disease: from xenodiagnosis and hemoculture to polymerase chain reaction].
    Portela-Lindoso AA; Shikanai-Yasuda MA
    Rev Saude Publica; 2003 Feb; 37(1):107-15. PubMed ID: 12488927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid, quantitative enzyme-linked immunosorbent assay (ELISA) for the immunodiagnosis of Chagas' disease.
    Partel CD; Rossi CL
    Immunol Invest; 1998; 27(1-2):89-96. PubMed ID: 9561920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-Trypanosoma cruzi antibody detection in eastern Andalusia (Spain).
    Marín C; Concha-Valdez F; Cañas R; Gutiérrez-Sánchez R; Sánchez-Moreno M
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):165-72. PubMed ID: 24463719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Standardization of Dot-ELISA for detection of anti-Trypanosoma cruzi antibodies, compared to ELISA and Western blot].
    Cervantes-Landín AY; Martínez-Martínez I; Reyes PA; Shabib M; Espinoza-Gutiérrez B
    Enferm Infecc Microbiol Clin; 2014; 32(6):363-8. PubMed ID: 23890693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High specificity of Trypanosoma cruzi epimastigote ribonucleoprotein as antigen in serodiagnosis of Chagas' disease.
    Solana ME; Katzin AM; Umezawa ES; Miatello CS
    J Clin Microbiol; 1995 Jun; 33(6):1456-60. PubMed ID: 7650167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Longitudinal follow up of serological response in children treated for Chagas disease.
    Moscatelli G; Moroni S; García Bournissen F; González N; Ballering G; Schijman A; Corral R; Bisio M; Freilij H; Altcheh J
    PLoS Negl Trop Dis; 2019 Aug; 13(8):e0007668. PubMed ID: 31465522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Next-generation ELISA diagnostic assay for Chagas Disease based on the combination of short peptidic epitopes.
    Mucci J; Carmona SJ; Volcovich R; Altcheh J; Bracamonte E; Marco JD; Nielsen M; Buscaglia CA; Agüero F
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005972. PubMed ID: 28991925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.